Recent Partnerships by Medical Device Contract Research Organization

Published: August 2025

Over the last decade, the landscape of outsourcing in the MedTech industry has witnessed a paradigm shift. The collaboration between MedTech companies and medical device contract research organization has evolved from one-time contracts to long-term strategic alliances.

In addition, as regulatory requirements in the industry continues to evolve, the medical device companies are increasingly seeking collaborations with established medical device contract research organizations. These strategic alliances allow the medical device companies to leverage the regulatory affairs expertise of their partners and facilitate smoother navigation throughout the evolving regulatory landscape for medical devices.

The future prospects of medical device contract research organization market appear promising, driven by increasing demand for novel medical devices, increasing R and D expenditure, ongoing technological advancements, growing emphasis on patient engagement solutions and stringent regulatory landscape.

Over the past few years, the medical device preclinical and clinical research CROs domain has witnessed a substantial increase in the mergers and acquisitions deals inked by medical device companies for the purpose of expanding / consolidating their portfolios. Notably, the majority of the deals inked were related to acquisitions owing to the rising competition within this domain due to the emergence of start-ups in recent years. This has compelled the existing medical device companies to diversify their CRO services and expand their global reach (through mergers and acquisitions) in order to access new markets and become one-stop shops.

Roots Analysis has conducted an exhaustive study on Medical Device CRO Market featuring the current landscape and future opportunity for the companies engaged in the medical device contract research organization domain. In this article, we have highlighted some of the recent partnership and collaborations by medical device contract research organization that are likely to shape the evolution of this sector.

Partnership and Collaborations Undertaken Medical Device CRO Market

Want to explore more about Medical Device CRO Market??

Recent Partnerships by Medical Device Contract Research Organization that Are Likely to Shape the Future Potential of the Industry

1. Strategic Investment between InTandem Capital and Clinilabs: Focus on Medical Devices for Central Nervous System

In March 2025, InTandem Capital announced a strategic investment in Clinilabs, a contract research organization, dedicated to the development and manufacturing of devices pertaining to central nervous system. Through this collaboration, the former company aims to accelerate the latter company’s innovation in medical device research for the development of advanced and innovative central nervous system solutions for patients worldwide.

2. Arterex Acquires Adroit: Strengthening Global Footprint and Manufacturing Capabilities

In February 2025, Arterex announced the acquisition of Adroit, in order to strengthen its contract research capabilities for medical devices. Adroit, headquartered in the US, is a contract manufacturer, which offers various types of medical devices, encompassing high-precision injection-molded plastic and metal components, as well as fully assembled and packaged products. Through this strategic acquisition, Arterex aims to offer tailored end-to-end solutions, streamline clinical development process and offer accelerated timelines to medical device companies for their medical devices.

3. Acquisition of Phoenix by Arterex: Expanding CRO Capabilities Across Diverse Medical Devices Through Acquisition

In February 2025, Arterex completed the acquisition of Phoenix, an Italy-based company dedicated to the design, development, assembly, and packaging of medical disposables. Through this acquisition, the company aims to offer an end-to-end solution for its client and expand its global reach, particularly in Europe. Further, this acquisition will allow the former company to streamline the development process for medical device companies and accelerate time-to-market by leveraging the latter company’s established development and manufacturing process.

4. Partnership Between Tigermed and Medidata: Accelerating Medical Device Clinical Trials Through CRO Collaboration

In January 2025, Tigermed announced the extension of its strategic partnership with Medidata, aimed to accelerate the clinical trials evaluating medical devices across the world. By leveraging the latter company’s Medidata platform, the former company aims at integrating advanced digital solutions to automate data capture and streamline traditional labor-intensive CRO operations. Through this collaboration, the company intends to optimize workflows from early-phase trials through post-marketing surveillance, so as to enable faster access to innovative therapies for patients worldwide.

5. Canyon Labs Acquires iuvo: Strengthening Comprehensive Medical Device Development Solutions

In January 2025, Canyon Labs completed the acquisition of iuvo BioScience’s lab services and consulting business. Through this acquisition, the company focused on expanding its CRO services, such as sterility and microbiology testing, biocompatibility testing, and material characterization and analytical testing. This allows the company to offer a more end-to-end solution for the medical device development process, from preclinical and clinical research services to consulting services.

6. NAMSA Acquires the US Medical Device Testing Operations of WuXi AppTec: Expanding Clinical Research and Testing solutions Portfolio

In January 2025, NAMSA completed the acquisition of the US medical device testing operations of WuXi AppTec, aimed to expand its clinical research and testing solutions portfolio. Through this acquisition, the company aims to expand its preclinical, clinical and laboratory testing services for various types of medical devices. Further, the company aims to accelerate the innovations in the MedTech industry and deliver life-saving medical technology solutions across the world. 6

Conclusion

The historical evolution of medical devices demonstrates a notable shift towards increased sophistication and heightened regulatory scrutiny, showcasing wider trends in both healthcare and technology. From ancient tools used for surgical procedures to modern devices, the evolution of medical devices has been marked by continuous innovation.

As the medical device industry has advanced, medical device contract research organization has become pivotal in supporting medical device companies through increasingly complex development processes. These organizations provide specialized expertise in navigating regulatory requirements, conducting clinical trials, and ensuring compliance with safety standards. The role of CROs has expanded beyond mere compliance; these organizations now foster innovation by leveraging new technologies and methodologies to streamline the medical device development processes. In addition to this, the medical device landscape is rapidly changing, driven by the advancements in material sciences, digital health technologies, and personalized medicines.

As these innovations present new opportunities for patient care, they also introduce complexities that require expert guidance to effectively navigate regulatory landscape. The synergy between manufacturers and medical device contract research organization will be crucial in ensuring that safe and effective medical devices reach patients efficiently, ultimately improving health outcomes and enhancing the quality of care across diverse populations

Browse our full report on Medical Device CRO Market: https://www.rootsanalysis.com/reports/medical-device-cros-market/226.html#overview

Sources: